The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design (Q28185278)
Jump to navigation
Jump to search
scientific article (publication date: May 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design |
scientific article (publication date: May 2003) |
Statements
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design (English)
0 references
1 May 2003
0 references
61
0 references
1
0 references
7-18
0 references